BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Capital Reinvestment Ratio
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Capital Reinvestment Ratio of 0.83x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs149.66 Million) in capital expenditures (Rs123.88 Million). Check tangible net worth ratio of BALAXI PHARMACEUTICALS LIMITED to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BALAXI PHARMACEUTICALS LIMITED Capital Reinvestment Ratio (2015–2024)
This chart tracks BALAXI PHARMACEUTICALS LIMITED's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see BALAXI PHARMACEUTICALS LIMITED (BALAXI) cash conversion ratio.
Annual Capital Reinvestment Ratio for BALAXI PHARMACEUTICALS LIMITED (2015–2024)
Year-by-year Capital Reinvestment Ratio for BALAXI PHARMACEUTICALS LIMITED from 2015 to 2024. See BALAXI PHARMACEUTICALS LIMITED free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | Rs48.66 Million | Rs15.69 Million | ▼ -86.9% |
| 2023 | 2.47x | Rs60.75 Million | Rs149.80 Million | ▲ +207.9% |
| 2022 | 0.80x | Rs341.44 Million | Rs273.44 Million | ▼ -99.9% |
| 2021 | 824.65x | Rs31.00K | Rs25.56 Million | ▲ +5861379.5% |
| 2015 | 0.01x | Rs2.11 Million | Rs29.72K | — |